FAT4 and lung carcinoma: (75) discovered that JUA is a novel activator of FAT4, a cancer suppressor in lung cancer, which causes cell cycle arrest primarily by activating the FAT4-Hippo signaling pathway and promoting YAP nuclear translocation.